Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01922934 · ClinicalTrials.gov registry record · Phase 4

A Toolbox Approach to Obesity Treatment in Primary Care

A Phase 4 study, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
Phase 4
Development phase
4,730
Enrollment target

NCT01922934: Completed Phase 4 study, sponsored by Denver Health and Hospital Authority.

NCT01922934 is a Phase 4 study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 4,730 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (813% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01922934, a Phase 4 study, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
Phase 4
Development phase
4,730 participants
Enrollment target

Study Summary

Obesity is common, causing many medical problems in adults (e.g., diabetes, hypertension, high cholesterol, sleep apnea, heart attack, strokes). A range of treatments have shown to be effective for treating obesity. Treatments include lifestyle modification, meal replacements, and weight loss medication. Most primary care settings do not provide much obesity treatment, though, as primary care providers (PCPs) are not well trained and because reimbursement for treatments is not consistent. Hypothesis: If PCPs have training in weight management and if most costs of treatment are reimbursed, we surmise that a "toolbox" of treatments can produce a clinically important weight loss amount in a large group of patients. Design: We propose to establish a registry of obese patients with at least one common medical condition related to their weight. From the registry, we will randomly select 350 people to be offered treatments to assist with weight loss. The remainder of the registry's patients can still receive obesity treatment but will not be reimbursed. We will conduct the study at Denver Health, a large public health care system that treats a low income, ethnically diverse population. All 350 patients will be offered some self-monitoring tools for weight management and the chance to do a computer assessment to select the right treatment for weight loss. Patients who complete this and record their food intake and physical activity for 1 week will be offered a "Level 2" treatment for weight loss. Level 2 treatments include: a voucher for a commercial weight loss program; intensive group weight loss counseling; meal replacements; gym membership; or weight loss medication. Patients will choose which treatment they want, with the approval of their PCP. Researchers at Denver Health will help with the computer assessment and dispensing the treatments. We are interested in what percentage of patients lose at least 5% of their starting weight. We will also explore changes in glu

Primary Outcome

Participants who had both a baseline and 12 month weight measurement were included. Weight change at 12 months was measured as a percent difference from their starting weight.

Interventions

  • BEHAVIORAL Commercial weight loss program
  • BEHAVIORAL Colorado Weigh
  • DIETARY_SUPPLEMENT Meal replacements
  • DRUG Obesity pharmacotherapy
  • BEHAVIORAL Recreation center passes

Trial Details

FieldValue
Enrollment Target 4,730 participants
Start Date 2014-01
Est. Completion 2016-08
Phase Phase 4

What the finished NCT01922934 record still lists

NCT01922934 is an interventional study that assigns participants to a tested intervention. Its 4,730 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (813% higher).

The record links to 0 conditions, and to 5 interventions - of which Commercial weight loss program is the first listed.

NCT01922934 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01922934 about?

NCT01922934 is a clinical study titled "A Toolbox Approach to Obesity Treatment in Primary Care". Obesity is common, causing many medical problems in adults (e.g., diabetes, hypertension, high cholesterol, sleep apnea, heart attack, strokes). A range of treatments have shown to be effective for treating obesity. Treatments include lifestyle modification, meal replacements, and weight loss medica...

What is the current status of trial NCT01922934?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,730 participants. The study started on 2014-01. Estimated completion is 2016-08.

What interventions are being tested in trial NCT01922934?

The interventions under investigation include: Commercial weight loss program (BEHAVIORAL), Colorado Weigh (BEHAVIORAL), Meal replacements (DIETARY_SUPPLEMENT), Obesity pharmacotherapy (DRUG), Recreation center passes (BEHAVIORAL).

Who is sponsoring clinical trial NCT01922934?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01922934's enrollment target sits among peer trials

4,730 17th of 2000 higher than 1,984 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04371900 · 4,700 participants · NA

    Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1

  • NCT05486572 · 4,700 participants · NA

    Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • NCT06888388 · 4,700 participants

    Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

  • NCT01719055 · 4,800 participants

    RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01922934, the US trial registry maintained by the National Library of Medicine. NCT01922934 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.